We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > TransThera Biosciences

News List

Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration prnasia
December 21, 2020
Teijin Pharma Limited, the core company of the Teijin Group's healthcare business headquartered in Tokyo, Japan, and TransThera Biosciences Co. Ltd., a clinical-stage biotechnology company based in Nanjing, China, jointly announced that they have ...
TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure firstwordpharma
December 17, 2019
TransThera Biosciences Co. Ltd, a clinical-stage biotechnology company based in Nanjing, China, announced today that the U.S. Food and Drug Administration (FDA) has granted the company's Investigational New Drug (IND) application for TT-00920, a novel sma
TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure prnasia
December 17, 2019
Under this IND, TransThera will initiate a Phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of TT-00920 in healthy volunteers. The trial is expected to initiate in early 2020.